Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction With Complement Inhibitor Eculizumab in Clinical Islet Transplantation

NCT02727608 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT02727608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02727608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction With Complement Inhibitor Eculizumab in Clinical Islet Transplantation
Lead sponsor
Uppsala University
Phase
Phase 2
Overall status
Completed
Start date
May 15, 2016
Completion date
June 30, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus